TCRT Alaunos Therapeutics Inc

-0.0044 (-3.34%)
Last Updated: 14:14:56
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 367,304
Bid Price 0.1274
Ask Price 0.1283
News -
Day High 0.1347


52 Week Range


Day Low 0.1263
Company Name Stock Ticker Symbol Market Type
Alaunos Therapeutics Inc TCRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0044 -3.34% 0.1274 14:14:56
Open Price Low Price High Price Close Price Prev Close
0.1294 0.1263 0.1347 0.1318
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
769 367,304 $ 0.129471 $ 47,555 - 0.1111 - 1.85
Last Trade Time Type Quantity Stock Price Currency
14:16:31 100 $ 0.1274 USD

Alaunos Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
30.87M 240.63M - 2.92M -37.73M -0.16 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Alaunos Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TCRT Message Board. Create One! See More Posts on TCRT Message Board See More Message Board Posts

Historical TCRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.12630.150.12630.1348501986,0380.00110.87%
1 Month0.14250.1550.11110.13431371,410,842-0.0151-10.6%
3 Months0.47620.50990.11110.17432482,204,332-0.3488-73.25%
6 Months0.620.6980.11110.25159681,333,478-0.4926-79.45%
1 Year1.751.850.11110.55724271,323,076-1.62-92.72%
3 Years0.8664.010.11111.082,111,573-0.7386-85.29%
5 Years0.8664.010.11111.082,111,573-0.7386-85.29%

Alaunos Therapeutics Description

Ziopharm Oncology Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Ziopharm Oncology Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Ziopharm Oncology Inc. ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.
Your Recent History
Alaunos Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now